person

Iris E.C. Sommer, Prof. Dr.

Iris EC Sommer, Prof. dr.Iris Sommer, PhDIris Sommer, Prof. Dr.Iris Sommer, Prof. dr.Iris Sommer, Prof., Dr.
ORCID 0000-0001-5597-3262
as of 2026-07-01
at a glance
Roles: Principal Investigator, Study Director, Author, Investigator+Author
KOL signal score 16
5 publications · 2 high-value
Cross-drug reach: 2 competitor drugs
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
University Medical Center Groningen
Roles
Principal Investigator, Study Director, Author, Investigator+Author
KOL signal
16
Publications
5 (2 high-value)
Trial investigator
yes

Publishes on

2 drugs

Trials led

6

Publications & congress

5
Clinical Practice Guideline on the Choice of First Antipsychotic Medicine for Females Experiencing a First-Episode of Psychosis.
Schizophrenia bulletin · 2026 · high-value
Triangulating evidence from the GALENOS living systematic review on trace amine-associated receptor 1 (TAAR1) agonists in psychosis.
The British journal of psychiatry : the journal of mental science · 2025 · high-value
Using AI to Detect Psychosis Relapse: Scoping Review.
JMIR mental health · 2026
Increasing participation of people with thought disorder in clinical research.
European psychiatry : the journal of the Association of European Psychiatrists · 2026
The global economic burden of schizophrenia: an umbrella review of systematic reviews and meta-analyses with reconstructed primary-study cost data.
Health economics review · 2026

Facts & assertions

0 sourced
No assertions recorded for this entity.